Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4213464)

Published in BMC Cancer on October 22, 2014


Qian Liu, Lifeng Yan, Cheng Xu, Aihua Gu1, Peng Zhao, Zhao-Yan Jiang

Author Affiliations

1: State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing 211166, China.

Articles cited by this

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06

Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99

Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature (1999) 3.93

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet (1998) 3.77

National Institutes of Health Consensus Development Conference Statement: liver transplantation--June 20-23, 1983. Hepatology (1984) 2.50

Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00

Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl (2008) 1.97

Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Liver Transpl (2008) 1.78

Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant (2010) 1.64

Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl (2005) 1.55

Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: the effect of smoking withdrawal. Liver Transpl (2011) 1.54

Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study. Int J Cancer (2012) 1.36

De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28

Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int (2010) 1.14

De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant (2004) 1.09

Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol (2001) 1.07

Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation (2000) 1.06

Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation (1999) 1.05

Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients. Transplantation (2007) 1.02

Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis (2009) 1.01

De novo tumors after liver transplantation: a single-institution experience. Liver Transpl (2002) 1.00

Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol (2005) 0.99

Post-transplant lymphoproliferative disease in liver transplantation. Br J Radiol (2007) 0.98

Alcohol and laryngeal cancer: an update. Eur J Cancer Prev (2008) 0.96

Non-lymphoid cancer after liver transplantation. Hepatogastroenterology (1997) 0.94

De novo tumors after orthotopic liver transplantation. Transplant Proc (2002) 0.90

Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report. Clin Transplant (2009) 0.89

De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Transplant Proc (2013) 0.88

Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol (2007) 0.88

Head and neck cancer in transplant recipients. Curr Opin Otolaryngol Head Neck Surg (2004) 0.87

De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Transplantation (2013) 0.85

Why do immunosuppressed patients develop cancer? Crit Rev Oncog (1989) 0.85

Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis. Am J Transplant (2010) 0.84

Causes and predisposing factors of de novo tumors in our series of liver transplant recipients. Transplant Proc (2009) 0.82

Thyroid cancer and renal transplantation: a meta-analysis. Endocr Relat Cancer (2010) 0.81

Cancer of the head and neck region in solid organ transplant recipients. Head Neck (2013) 0.78

Noncutaneous head and neck cancer in solid organ transplant patients: single center experience. Oral Oncol (2014) 0.77

Cancer in organ transplant recipients: part of an induced immune deficiency syndrome. Br Med J (Clin Res Ed) (1984) 0.77

Synergistic effects of azathioprine and ultraviolet light detected by sister chromatid exchange analysis. Cancer Genet Cytogenet (1990) 0.77

Treatment of mucor infection after liver or pancreas-kidney transplantation. Transplant Proc (2002) 0.76

Psychosocial factors in noncompliance during liver transplant selection. J Clin Psychol Med Settings (2010) 0.76

Articles by these authors

(truncated to the top 100)

RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell (2009) 11.12

Coupling of the nucleus and cytoplasm: role of the LINC complex. J Cell Biol (2005) 6.47

A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res (2004) 5.21

hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res (2008) 3.20

Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab (2006) 2.64

Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization. Proc Natl Acad Sci U S A (2009) 2.59

Micro-optical sectioning tomography to obtain a high-resolution atlas of the mouse brain. Science (2010) 2.47

Super-resolution fluorescence imaging of organelles in live cells with photoswitchable membrane probes. Proc Natl Acad Sci U S A (2012) 2.46

The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol Cell (2006) 2.24

SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res (2010) 2.20

The multi-ethnic pediatric eye disease study: design and methods. Ophthalmic Epidemiol (2006) 2.02

Structural role of countertransport revealed in Ca(2+) pump crystal structure in the absence of Ca(2+). Proc Natl Acad Sci U S A (2005) 2.02

An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice. J Bone Miner Res (2013) 1.85

Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy. Theranostics (2011) 1.83

A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A (2004) 1.79

ABO3, a WRKY transcription factor, mediates plant responses to abscisic acid and drought tolerance in Arabidopsis. Plant J (2010) 1.74

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood (2014) 1.66

The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res (2012) 1.66

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood (2011) 1.65

White matter hyperintensities and dynamics of postural control. Magn Reson Imaging (2009) 1.60

Predicting soil erosion for alternative land uses. J Environ Qual (2006) 1.58

Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials (2011) 1.56

Sema3A regulates bone-mass accrual through sensory innervations. Nature (2013) 1.53

Exogenous silicon (Si) increases antioxidant enzyme activity and reduces lipid peroxidation in roots of salt-stressed barley (Hordeum vulgare L.). J Plant Physiol (2003) 1.53

Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus. Hepatology (2013) 1.53

Plant phenomics and high-throughput phenotyping: accelerating rice functional genomics using multidisciplinary technologies. Curr Opin Plant Biol (2013) 1.52

Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer. Clin Cancer Res (2011) 1.51

Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug. Blood (2010) 1.48

Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury. J Mol Cell Cardiol (2008) 1.44

Role of IL-10-Producing Regulatory B Cells in Chronic Hepatitis B Virus Infection. Dig Dis Sci (2014) 1.44

Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer. Dig Dis Sci (2013) 1.43

Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes. J Cell Biol (2011) 1.42

BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci (2009) 1.40

Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. World J Gastroenterol (2005) 1.39

RTE1 is a Golgi-associated and ETR1-dependent negative regulator of ethylene responses. Plant Physiol (2007) 1.39

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med (2011) 1.38

Decreased regional homogeneity in insula and cerebellum: a resting-state fMRI study in patients with major depression and subjects at high risk for major depression. Psychiatry Res (2010) 1.38

Supervised learning-based cell image segmentation for p53 immunohistochemistry. IEEE Trans Biomed Eng (2006) 1.36

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer (2009) 1.35

A reproducible brain tumour model established from human glioblastoma biopsies. BMC Cancer (2009) 1.35

Nonlinear assessment of cerebral autoregulation from spontaneous blood pressure and cerebral blood flow fluctuations. Cardiovasc Eng (2008) 1.35

Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Carcinogenesis (2009) 1.35

Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology (2012) 1.34

Receptor signal output mediated by the ETR1 N terminus is primarily subfamily I receptor dependent. Plant Physiol (2006) 1.34

Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology (2009) 1.34

Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis. J Mol Cell Cardiol (2009) 1.33

Health care in China: improvement, challenges, and reform. Chest (2013) 1.31

MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLoS One (2012) 1.31

In situ self-assembly of mild chemical reduction graphene for three-dimensional architectures. Nanoscale (2011) 1.29

IL-2 and autocrine IL-4 drive the in vivo development of antigen-specific Th2 T cells elicited by nematode parasites. J Immunol (2005) 1.29

Human health risk from soil heavy metal contamination under different land uses near Dabaoshan Mine, Southern China. Sci Total Environ (2012) 1.29

Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. J Clin Invest (2010) 1.28

Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem (2005) 1.26

Requirements for the development of IL-4-producing T cells during intestinal nematode infections: what it takes to make a Th2 cell in vivo. Immunol Rev (2004) 1.24

Transposons inactivate biosynthesis of the nonribosomal peptide microcystin in naturally occurring Planktothrix spp. Appl Environ Microbiol (2006) 1.24

Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Clin Cancer Res (2009) 1.24

CADgene: a comprehensive database for coronary artery disease genes. Nucleic Acids Res (2010) 1.23

The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem (2007) 1.22

Hydrophilic Cu9S5 nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo. ACS Nano (2011) 1.21

Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology (2009) 1.21

Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab (2010) 1.20

Upconversion luminescent materials: advances and applications. Chem Rev (2014) 1.19

Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells. Nucleic Acids Res (2012) 1.19

Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care (2011) 1.18

High-throughput measurement of rice tillers using a conveyor equipped with x-ray computed tomography. Rev Sci Instrum (2011) 1.18

Laser speckle imaging of blood flow in microcirculation. Phys Med Biol (2004) 1.18

Controllable N-doping of graphene. Nano Lett (2010) 1.18

Surface plasmon-coupled emission: what can directional fluorescence bring to the analytical sciences? Annu Rev Anal Chem (Palo Alto Calif) (2012) 1.17

Oxidative stress-induced JNK1/2 activation triggers proapoptotic signaling and apoptosis that leads to diabetic embryopathy. Diabetes (2012) 1.17

Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis. Blood (2010) 1.17

The role of OX40 ligand interactions in the development of the Th2 response to the gastrointestinal nematode parasite Heligmosomoides polygyrus. J Immunol (2003) 1.17

Epidemiology and clinical presentation of the four human parainfluenza virus types. BMC Infect Dis (2013) 1.16

Soil microbial biomass, basal respiration and enzyme activity of main forest types in the Qinling Mountains. PLoS One (2013) 1.16

Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury. J Neurosci (2008) 1.15

Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int J Oncol (2009) 1.15

sRNATarBase: a comprehensive database of bacterial sRNA targets verified by experiments. RNA (2010) 1.14

AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome. J Cell Mol Med (2011) 1.14

Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells. Mol Cell (2012) 1.13

Ca2+ occlusion and gating function of Glu309 in the ADP-fluoroaluminate analog of the Ca2+-ATPase phosphoenzyme intermediate. J Biol Chem (2004) 1.13

An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J Pathol (2005) 1.12

Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings. J Hepatol (2013) 1.12

Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers. Biosens Bioelectron (2004) 1.10

Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol (2002) 1.09

c-Jun NH2-terminal kinase 1/2 and endoplasmic reticulum stress as interdependent and reciprocal causation in diabetic embryopathy. Diabetes (2012) 1.09

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis. PLoS One (2013) 1.08

miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10. BMC Cancer (2012) 1.08

Combinatorial Optimization of (Lu₁₋(x)Gd(x))₃Al₅O₁₂:Ce₃(y) yellow phosphors as precursors for ceramic scintillators. ACS Comb Sci (2010) 1.07

Solution structure of the carbon storage regulator protein CsrA from Escherichia coli. J Bacteriol (2005) 1.07

Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker. BMC Cancer (2013) 1.06

Structural reorganization of the interleukin-7 signaling complex. Proc Natl Acad Sci U S A (2012) 1.06

Self-supported nanoporous cobalt phosphide nanowire arrays: an efficient 3D hydrogen-evolving cathode over the wide range of pH 0-14. J Am Chem Soc (2014) 1.06


Antioxidant activity of black currant (Ribes nigrum L.) extract and its inhibitory effect on lipid and protein oxidation of pork patties during chilled storage. Meat Sci (2012) 1.05

Evaluation and application of multiple scoring functions for a virtual screening experiment. J Comput Aided Mol Des (2004) 1.05

Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1α accumulation via phosphatidylinositol 3-kinase/Akt pathway. J Pharmacol Exp Ther (2011) 1.05

Pain sensitivity and autonomic factors associated with development of TMD: the OPPERA prospective cohort study. J Pain (2013) 1.05

Autophagic pathways as new targets for cancer drug development. Acta Pharmacol Sin (2010) 1.05

Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology (2009) 1.04

Maternal hyperglycemia activates an ASK1-FoxO3a-caspase 8 pathway that leads to embryonic neural tube defects. Sci Signal (2013) 1.04

Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons. J Neurosci (2013) 1.04